{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:38:19Z","timestamp":1791221899582,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cFonds pour la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.)\u201d"},{"DOI":"10.13039\/501100006673","name":"\u201cLeon Fredericq Foundation\u201d","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006673","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejmech.2013.12.033","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T06:45:34Z","timestamp":1388817934000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: Cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism"],"prefix":"10.1016","volume":"74","author":[{"given":"Jean-Fran\u00e7ois","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Pirotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.12.033_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jss.2007.04.040","article-title":"The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E\u2212\/\u2212 mice","volume":"146","author":"Jacob","year":"2008","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.ejmech.2013.12.033_bib2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2006.01.036","article-title":"Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage","volume":"50","author":"Dassesse","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib3","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1021\/jm100398z","article-title":"Synthesis, anti-inflammatory activity, and in\u00a0vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones","volume":"53","author":"Harrak","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.12.033_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopha.2012.04.002","article-title":"Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer","volume":"66","author":"Nadda","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2013.12.033_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jnci\/djn324","article-title":"Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis","volume":"100","author":"Takkouche","year":"2008","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2013.12.033_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/156802608783334042","article-title":"Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage","volume":"8","author":"Kukar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2007.09.004","article-title":"NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?","volume":"28","author":"Weggen","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2013.12.033_bib9","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New. Biol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/bega.2001.0229","article-title":"Pathogenesis of NSAID-induced gastroduodenal mucosal injury","volume":"15","author":"Wallace","year":"2001","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2000.9561","article-title":"Nonsteroidal anti-inflammatory drug gastropathy","volume":"119","author":"Hawkey","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2013.12.033_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.12.033_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","article-title":"Gastrointestinal safety of cyclooxygenase-2 inhibitors: a cochrane collaboration systematic review","volume":"5","author":"Rostom","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.12.033_bib16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"I.\u00a0Adenomatous polyp prevention on Vioxx trial, cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.12.033_bib17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMe058042","article-title":"COX-2 inhibitors-lessons in drug safety","volume":"352","author":"Psaty","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.12.033_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0960-894X(99)00288-7","article-title":"The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor","volume":"9","author":"Prasit","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.12.033_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/jm990577v","article-title":"4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2","volume":"43","author":"Talley","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2174\/0929867043365279","article-title":"New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators","volume":"11","author":"de Leval","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2174\/0929867043365260","article-title":"New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators","volume":"11","author":"Dogn\u00e9","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.coph.2005.02.001","article-title":"Cardiovascular hazard and non-steroidal anti-inflammatory drugs","volume":"5","author":"Wang","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/cbdv.200900421","article-title":"Nitrooxymethyl-substituted analogues of rofecoxib: synthesis and pharmacological characterization","volume":"7","author":"Boschi","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2013.12.033_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.bmcl.2010.01.014","article-title":"Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies","volume":"20","author":"Chowdhury","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.12.033_bib25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1021\/jm101403g","article-title":"Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies","volume":"54","author":"Huang","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib26","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1021\/jm2004514","article-title":"New nitric oxide or hydrogen sulfide releasing aspirins","volume":"54","author":"Lazzarato","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib27","first-page":"147","article-title":"Vascular nitric oxide: formation and function","volume":"2010","author":"Jin","year":"2010","journal-title":"J.\u00a0Blood Med."},{"key":"10.1016\/j.ejmech.2013.12.033_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2007.09.003","article-title":"Hydrogen sulfide-releasing anti-inflammatory drugs","volume":"28","author":"Wallace","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2013.12.033_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/jm901269y","article-title":"Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in\u00a0vitro and in\u00a0vivo biological evaluation","volume":"53","author":"Biava","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib30","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/jm200063s","article-title":"Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase","volume":"54","author":"Chen","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/msb.2008.60","article-title":"Finding multiple target optimal intervention in disease-related molecular network","volume":"4","author":"Yang","year":"2008","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib32","first-page":"132","article-title":"4-Nitro-2-phenoxymethanesulfonanilide (R-805): a chemically novel anti-inflammatory agent","volume":"221","author":"Swingle","year":"1976","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejmech.2013.12.033_bib33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-3565(24)37830-9","article-title":"Selective cyclooxygenase-2 inhibition by nimesulide in man","volume":"287","author":"Cullen","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2013.12.033_bib34","first-page":"596","article-title":"Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System","volume":"72","author":"Macia","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2013.12.033_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.327.7405.18","article-title":"Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs","volume":"327","author":"Traversa","year":"2003","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2013.12.033_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/tx800152r","article-title":"In\u00a0vitro nimesulide studies toward understanding idiosyncratic hepatotoxicity: diiminoquinone formation and conjugation","volume":"22","author":"Li","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib37","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1021\/jm020920n","article-title":"Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors","volume":"45","author":"Julemont","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib38","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1021\/jm049480l","article-title":"Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors","volume":"47","author":"Julemont","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib39","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1021\/jm900702b","article-title":"Pyridine analogues of nimesulide: design, synthesis, and in\u00a0vitro and in\u00a0vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors","volume":"52","author":"Renard","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.12.033_bib40","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/cber.19190520840","article-title":"Das am Ringkohlenstoff gebundene Halogen und sein Ersatz durch andere substituenten. I. Mitteilung: Ersatz des Halogens durch die Carboxylgruppe","volume":"52","author":"Rosenmund","year":"1919","journal-title":"Ber. Dtsch. Chem. Ges. A and B Ser."},{"key":"10.1016\/j.ejmech.2013.12.033_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1054\/plef.2001.0262","article-title":"Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood","volume":"64","author":"de Leval","year":"2001","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ejmech.2013.12.033_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2210-4-25","article-title":"Inhibitory effects of proanthocyanidins from Ribes nigrum leaves on carrageenin acute inflammatory reactions induced in rats","volume":"4","author":"Garbacki","year":"2004","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ejmech.2013.12.033_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2567.2005.02148.x","article-title":"Increased carrageenan-induced acute lung inflammation in old rats","volume":"115","author":"Corsini","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2013.12.033_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0731-7085(98)00172-1","article-title":"Mass spectrometric characterization and HPLC determination of the main urinary metabolites of nimesulide in man","volume":"18","author":"Carini","year":"1998","journal-title":"J.\u00a0Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2013.12.033_bib45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/00498254.2010.501117","article-title":"In\u00a0vitro and in\u00a0vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys","volume":"40","author":"Reddy","year":"2010","journal-title":"Xenobiotica"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413008210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413008210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:07:02Z","timestamp":1746097622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413008210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":45,"alternative-id":["S0223523413008210"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.12.033","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: Cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}